SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-19-011990
Filing Date
2019-06-13
Accepted
2019-06-13 17:22:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 navb20190613_424b5.htm 424B5 457615
2 a4.jpg GRAPHIC 12829
3 logo1.jpg GRAPHIC 8241
4 logo2.jpg GRAPHIC 14063
  Complete submission text file 0001437749-19-011990.txt   507272
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-222092 | Film No.: 19896926
SIC: 2835 In Vitro & In Vivo Diagnostic Substances